clodronic acid has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashi, K; Kumagai, H; Kushiyama, T; Miura, S; Oda, T; Oshima, N; Sakurai, Y; Yamada, M; Yamamoto, K | 1 |
1 other study(ies) available for clodronic acid and Encapsulating Peritoneal Sclerosis
Article | Year |
---|---|
Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
Topics: Animals; Anti-Infective Agents; Biomarkers; Blotting, Western; Bone Density Conservation Agents; Cells, Cultured; Chlorhexidine; Clodronic Acid; Immunoenzyme Techniques; Injections, Intraperitoneal; Liposomes; Macrophages, Peritoneal; Male; Neutrophils; Peritoneal Fibrosis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta1 | 2011 |